Verteporfin therapy for subfoveal choroidal neovascularization in age-related macular degeneration: four-year results of an open-label extension of 2 randomized clinical trials: TAP Report No. 7

Arch Ophthalmol. 2005 Sep;123(9):1283-5. doi: 10.1001/archopht.123.9.1283.
No abstract available

Publication types

  • Clinical Trial
  • Letter
  • Randomized Controlled Trial
  • Comment

MeSH terms

  • Aged
  • Choroidal Neovascularization / drug therapy*
  • Choroidal Neovascularization / etiology
  • Female
  • Follow-Up Studies
  • Humans
  • Macular Degeneration / complications
  • Macular Degeneration / drug therapy*
  • Male
  • Photochemotherapy*
  • Photosensitizing Agents / therapeutic use*
  • Porphyrins / therapeutic use*
  • Time Factors
  • Verteporfin
  • Visual Acuity

Substances

  • Photosensitizing Agents
  • Porphyrins
  • Verteporfin